NL-OMON30690
Completed
Phase 4
Farmacokinetics and farmacodynamics of drugs used in neonates and children during Extracorporal Membanous Oxygenation (ECMO) - farmacotherapy during ECMO
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- patienten aan ECMO
- Sponsor
- Erasmus MC, Universitair Medisch Centrum Rotterdam
- Enrollment
- 100
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •neonates and children 0\-18 year on ECMO
Exclusion Criteria
- •Witheld informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Pharmacokinetic, pharmacodynamic and pharmacogenetic research on biomarkers in cancer patients with special response to pharmacological therapyMalignancyJPRN-UMIN000011798Medical Oncology / Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine600
Completed
Not Applicable
Analysis of pharmacokinetics and pharmacodynamics for capecitabine during new chemotherapy regimen by bevacizumab (Bev) in combination with XELOX in unresectable colorectal cancerunresectable colorectal cancerJPRN-UMIN000013038Tsukasa Hotta10
Recruiting
Not Applicable
Pharmacokinetics, pharmacodynamics and pharmacogenomics of busulphan and other agents used in blood or marrow transplantatioACTRN12612000544875The Children's Hospital at Westmead300
Recruiting
Not Applicable
Pharmacokinetics, pharmacodynamics and pharmacogenetics study of eribulin mesylate in patients with unresectable advanced or recurrent breast cancernresectable advanced or recurrent breast cancerJPRN-UMIN000011693ational Cancer Center Hospital50
Not yet recruiting
Not Applicable
A study on the pharmacokinetics and pharmacodynamics of remimazolam during total intravenous anesthesia with remifentanilNot ApplicableKCT0007066Inje University Busan Paik Hospital15